Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
Clinical trial NCT00050726 · COMPLETED
Trial details
- NCT number
- NCT00050726
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2006-04-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.